189 related articles for article (PubMed ID: 30092149)
1. Combination therapies for hypertension - why we need to look beyond RAS blockers.
Gorostidi M; de la Sierra A
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):841-853. PubMed ID: 30092149
[TBL] [Abstract][Full Text] [Related]
2. Management of hypertension with fixed-dose triple-combination treatments.
Epstein BJ; Shah NK; Borja-Hart NL
Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T
Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969
[TBL] [Abstract][Full Text] [Related]
4. Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations.
de la Sierra A; Banegas JR; Vinyoles E; Gorostidi M; Segura J; de la Cruz JJ; Ruilope LM
Clin Exp Hypertens; 2016; 38(4):409-14. PubMed ID: 27159660
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy as first-line treatment for hypertension.
Crawford MH
Am J Cardiovasc Drugs; 2009; 9(1):1-6. PubMed ID: 19178127
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with Renin-Angiotensin-aldosterone receptor blockers for hypertension: how far have we come?
Weir MR; Bakris GL
J Clin Hypertens (Greenwich); 2008 Feb; 10(2):146-52. PubMed ID: 18256579
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?
Taddei S
Am J Cardiovasc Drugs; 2015 Jun; 15(3):185-94. PubMed ID: 25850749
[TBL] [Abstract][Full Text] [Related]
8. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
Lazich I; Bakris GL
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
[TBL] [Abstract][Full Text] [Related]
9. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
[TBL] [Abstract][Full Text] [Related]
10. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
[TBL] [Abstract][Full Text] [Related]
11. Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.
Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):255-263. PubMed ID: 28608025
[TBL] [Abstract][Full Text] [Related]
12. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
Volpe M; Tocci G; de la Sierra A; Kreutz R; Laurent S; Manolis AJ; Tsioufis K
High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):463-472. PubMed ID: 29086364
[TBL] [Abstract][Full Text] [Related]
13. Hypertension management: rationale for triple therapy based on mechanisms of action.
Neutel JM; Smith DH
Cardiovasc Ther; 2013 Oct; 31(5):251-8. PubMed ID: 23121769
[TBL] [Abstract][Full Text] [Related]
14. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
15. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
Schmieder RE
Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
[TBL] [Abstract][Full Text] [Related]
16. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
Verdecchia P; Gentile G; Angeli F; Reboldi G
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
[TBL] [Abstract][Full Text] [Related]
17. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
19. [Arterial Hypertension - when are which combination therapies useful?].
Brenner R; Rimoldi SF; Rexhaj E; Allemann Y
Ther Umsch; 2012 May; 69(5):305-13. PubMed ID: 22547363
[TBL] [Abstract][Full Text] [Related]
20. Evolving strategies for the use of combination therapy in hypertension.
Gradman AH; Acevedo C
Curr Hypertens Rep; 2002 Oct; 4(5):343-9. PubMed ID: 12217251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
